홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NKTR
#1941
Nektar Therapeutics
73.250
0
USD
+4.11%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.11%
월간 변동
-0.03%
6달 변화
-0.03%
년간 변동율
-0.03%
이전 종가
70.360
0
Open
73.250
0
Bid
73.250
0
Ask
73.253
0
Low
73.250
0
High
73.250
0
양
66
마켓
주식
헬스케어
NKTR
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
12.15 M
12.42 M
12.62 M
12.24 M
12.41 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.29
0.47
0.52
0.69
0.39
0.49
Return on equity %
0.41
0.77
1
2.11
1.96
5.72
Return on invested capital %
254.72
426.37
531.3
747.1
563.62
829.6
Gross margin %
87.26
75.57
76.5
62.53
68.82
372.66
Operating margin %
278
437.76
408.63
292.59
106.88
969.43
EBITDA margin %
17.71
-46.1
-160.53
-202.78
-17.91
-1 441.57
Net margin %
290.65
514.03
399.98
306.31
120.86
1 135.04
Liquidity ratios
Quick ratio
9.7
9.15
7.72
6.14
4.26
—
Current ratio
9.83
9.34
8
6.45
4.26
14.35
Inventory turnover
1.39
1.6
1.24
1.91
3.81
—
Asset turnover
0.09
0.08
0.1
0.16
0.28
0.23
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
26.31
33.77
24.37
15.21
12.82
12.68
EBIT per share
1.22
-4.91
-12.82
-14.98
-1.58
-12.37
EBITDA per share
2.27
-3.84
-11.84
-14.43
-1.29
-12.03
Total debt per share
—
—
—
—
—
—
Cash per share
89.19
60.06
40.48
23.97
18.62
60.91
Net current asset value per share
95.59
65.11
43.76
26.11
19.06
63.5
Tangible book value per share
84.06
49.35
23.26
10.34
4.43
11.62
Working capital per share
85.86
58.13
38.3
22.06
14.58
45.41
Book value per share
90.49
55.61
29.39
10.34
4.43
11.62
뉴스
오펜하이머, 넥타테라퓨틱스 목표 주가 $140로 상향
Oppenheimer raises Nektar Therapeutics price target to $140
넥타테라퓨틱스, 52주 신고가 경신… 76.3 USD 기록
Nektar Therapeutics stock hits 52-week high at 76.3 USD
넥타테라퓨틱스, 현금 확충 및 R&D 확장
Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
Nektar Therapeutics stock hits 52-week high at 75.19 USD
넥타테라퓨틱스, 4.6억 달러 규모 공모 마감